CAS: 251356-45-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
SU 16f REF: AN-AG00C4IJCAS: 251356-45-3 | ≥98%(HPLC) | 299,00 €~1.699,00 € | Vie 03 May 24 | |
SU16f REF: TM-T16947CAS: 251356-45-3 | 98% | 74,00 €~711,00 € | Lun 06 May 24 | |
PDGFR Tyrosine Kinase Inhibitor VII REF: 3D-BKA35645CAS: 251356-45-3 | Min. 95% | A consultar | Vie 14 Jun 24 |
Ref: AN-AG00C4IJ
5mg | 299,00 € | |
10mg | 503,00 € | |
25mg | 1.004,00 € | |
50mg | 1.699,00 € |
Entrega estimada en Estados Unidos, el Viernes 3 de Mayo de 2024
SU16f
CAS:251356-45-3
SU16f (3-substituted indolin-2-one 16f) is a potent and selective PDGFRβ inhibitor (IC50s: 10 nM, 140 …
Fórmula:
C24H22N2O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
386.44
Ref: TM-T16947
1mg | 74,00 € | |
5mg | 143,00 € | |
10mg | 200,00 € | |
25mg | 334,00 € | |
50mg | 495,00 € | |
100mg | 711,00 € | |
1ml*10 (DMSO) | 161,00 € |
Entrega estimada en Estados Unidos, el Lunes 6 de Mayo de 2024
PDGFR Tyrosine Kinase Inhibitor VII
CAS:251356-45-3
PDGFR Tyrosine Kinase Inhibitor VII is a protein-based drug that binds to the PDGFR tyrosine …
Fórmula:
C24H22N2O3
Pureza:
Min. 95%
Peso molecular:
386.44 g/mol
Ref: 3D-BKA35645
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 14 de Junio de 2024